Microbiota-Regulated Outcomes of Human Cancer Immunotherapy via the PD-1/PD-L1 Axis

Biochemistry

Volumn 57, Issue 6, 2018, Pages 901-903

  Patel, Jaymin ^a   Crawford, Jason M ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; ANTIBODY; CD274 PROTEIN, HUMAN; PDCD1 PROTEIN, HUMAN;

AKKERMANSIA MUCINIPHILA; BIOSYNTHESIS; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INTESTINE FLORA; MICROFLORA; MOLECULAR INTERACTION; MOLECULARLY TARGETED THERAPY; NONHUMAN; NOTE; POPULATION ABUNDANCE; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR ESCAPE; TUMOR GROWTH; VERRUCOMICROBIA; ANIMAL; ANTAGONISTS AND INHIBITORS; IMMUNOLOGY; IMMUNOTHERAPY; MICROBIOLOGY; NEOPLASM; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES; B7-H1 ANTIGEN; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOTHERAPY; NEOPLASMS; PROGRAMMED CELL DEATH 1 RECEPTOR; TREATMENT OUTCOME;

EID: 85042059939     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.7b01249     Document Type: Note

References (7)

1. Some illustration components were sourced from Servier Medical Art.
2. Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., Chang, E. B., and Gajewski, T. F. (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy Science 350, 1084-1089 10.1126/science.aac4255
3. Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., Fidelle, M., Flament, C., Poirier-Colame, V., Opolon, P., Klein, C., Iribarren, K., Mondragón, L., Jacquelot, N., Qu, B., Ferrere, G., Clémenson, C., Mezquita, L., Masip, J. R., Naltet, C., Brosseau, S., Kaderbhai, C., Richard, C., Rizvi, H., Levenez, F., Galleron, N., Quinquis, B., Pons, N., Ryffel, B., Minard-Colin, V., Gonin, P., Soria, J.-C., Deutsch, E., Loriot, Y., Ghiringhelli, F., Zalcman, G., Goldwasser, F., Escudier, B., Hellmann, M. D., Eggermont, A., Raoult, D., Albiges, L., Kroemer, G., and Zitvogel, L. (2017) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors Science 10.1126/science.aan3706
4. Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., Cogdill, A. P., Zhao, L., Hudgens, C. W., Hutchinson, D. S., Manzo, T., Petaccia de Macedo, M., Cotechini, T., Kumar, T., Chen, W. S., Reddy, S. M., Sloane, R. S., Galloway-Pena, J., Jiang, H., Chen, P. L., Shpall, E. J., Rezvani, K., Alousi, A. M., Chemaly, R. F., Shelburne, S., Vence, L. M., Okhuysen, P. C., Jensen, V. B., Swennes, A. G., McAllister, F., Sanchez, E. M. R., Zhang, Y., Le Chatelier, E., Zitvogel, L., Pons, N., Austin-Breneman, J. L., Haydu, L. E., Burton, E. M., Gardner, J. M., Sirmans, E., Hu, J., Lazar, A. J., Tsujikawa, T., Diab, A., Tawbi, H., Glitza, I. C., Hwu, W. J., Patel, S. P., Woodman, S. E., Amaria, R. N., Davies, M. A., Gershenwald, J. E., Hwu, P., Lee, J. E., Zhang, J., Coussens, L. M., Cooper, Z. A., Futreal, P. A., Daniel, C. R., Ajami, N. J., Petrosino, J. F., Tetzlaff, M. T., Sharma, P., Allison, J. P., Jenq, R. R., and Wargo, J. A. (2017) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients Science 10.1126/science.aan4236
5. Vandeputte, D., Kathagen, G., D'hoe, K., Vieira-Silva, S., Valles-Colomer, M., Sabino, J., Wang, J., Tito, R. Y., De Commer, L., Darzi, Y., Vermeire, S., Falony, G., and Raes, J. (2017) Quantitative microbiome profiling links gut community variation to microbial load Nature 10.1038/nature24460
6. Palm, N. W., de Zoete, M. R., and Flavell, R. A. (2015) Immune-microbiota interactions in health and disease Clin. Immunol. 159, 122-127 10.1016/j.clim.2015.05.014
7. Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., and Gajewski, T. F. (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients Science 359, 104-108 10.1126/science.aao3290